MTOR and hepatocellular carcinoma: We demonstrated that dual targeting of AKT and mTOR has a synergistic effect on the inhibition of HCC cell proliferation in vitro as well as on tumor growth and survival in a subcutaneous xenotransplantation mouse model in vivo [38].